Alphatec Holdings, Inc. (ATEC)

Over the past six months, Alphatec Holdings, Inc. (ATEC) stock has experienced a decline. Significant insider selling activity has occurred, including sales by a VP, the CFO, and the COO. ATEC reported strong Q4 and full-year 2025 financial results, with revenue increases and positive adjusted EBITDA. For 2026, management guided revenue to $890 million and raised adjusted EBITDA guidance to $134 million. Alphatec has a consensus rating of "Moderate Buy" from analysts, with a consensus price target of $22.82.

Explicit information regarding demand seasonality for Alphatec Holdings, Inc.'s products and services was not found in the provided search results. However, the company is positioned to capitalize on a growing demand for advanced spinal surgery technologies. Its focus on innovative spine solutions and expanding minimally invasive offerings positions it for sustained revenue growth amid rising global spine care demand. The company has demonstrated strong year-over-year revenue growth driven by a significant increase in surgical procedure volume.

Alphatec Holdings, Inc. (ATEC) is a medical technology company specializing in innovative solutions for spinal surgery. Founded in 1990 and headquartered in Carlsbad, California, ATEC operates within the Healthcare sector and the Medical Devices industry. The company's mission is to revolutionize spine surgery by providing surgeons with cutting-edge tools and technologies to improve patient outcomes. ATEC's core business segments include spinal implants, advanced surgical instruments, and biologics. The Alpha InformatiX product platform integrates systems for enhanced surgical experience through real-time analytics and visualization.

Alphatec Holdings, Inc. is headquartered in Carlsbad, California, United States. The company designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.

Alphatec Holdings, Inc. maintains a reputation for focusing on surgical innovation to address challenges faced by surgeons in spinal procedures. The company is committed to improving surgical techniques and patient outcomes through its robust pipeline of products. ATEC has seen strong surgeon adoption, with active users increasing by 26% year-over-year in Q3 2025 to over 700, boosting procedures and market share gains. Its integrated AI-enabled procedural ecosystem is positioning Alphatec for significant market share gains and premium pricing opportunities. No specific events negatively impacted Alphatec Holdings, Inc.'s brand reputation in the past year were found in the search results.

Alphatec Holdings, Inc. (ATEC) is primarily owned by institutional shareholders, who hold approximately 78.83% to 78.06% of the company's stock. Insiders own around 20.90% to 40.11% of the stock, while retail investors hold a smaller percentage, approximately 0.00% to 13.29%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and American Century Companies Inc. Significant individual/insider owners include Hgp II LLC and John I. Foster.